v3.26.1
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:        
Net loss from continuing operations $ (2,483,713) $ (1,557,171) $ (8,712,543) $ (6,201,734)
Net income from discontinued operations 3,573
Net loss (2,483,713) (1,557,171) (8,712,543) (6,198,161)
Adjustments to reconcile net loss to net cash used in operating activities        
Non-cash interest expense 1,006,782 14,241 1,166,614 1,119,461
Amortization and depreciation 52,539 54,305 208,553 214,372
Loss (gain) on fair value change of derivatives 30,273 (111,759) 1,621,028 (1,005,585)
Inventory write down 134,025
Gain on sale of building to a related party     (86,250)
Stock compensation expense 48,000 40,000
Changes in operating assets and liabilities:        
Accounts receivable (5,198) 31,895 58,424 88,767
Inventory 2,480 (543) (107,007) 945,281
Prepaid expenses (11,089) 7,269 32,792 10,251
Accounts payable and accrued expenses 849,031 785,580 3,395,713 2,920,894
Related party liabilities 95,000 80,000 721,600 60,000
Deferred revenue (2,494) 7,865 29,815 12,115
Operating lease liabilities (41,332) (39,192) (161,125) (147,993)
Customer deposits 2,688    
Net cash used in continuing operations (459,721) (724,822) (1,792,386) (1,846,573)
Net cash used in discontinued operations (3,573)
Net cash used in operating activities (459,721) (724,822) (1,792,386) (1,850,146)
Cash flows from investing activities:        
Purchase of office and computer equipment (3,490) (3,490) (11,114)
Loan to a related party in exchange for a promissory note receivable (175,000) (150,000)
Proceeds from sale of building to a related party     100,000
Net cash used in investing activities (175,000) (3,490) (53,490) (11,114)
Cash flows from financing activities:        
Proceeds from sale of common stock, net of costs 47,069 260,805 392,168 1,212,370
Proceeds from issuances of convertible notes payable, net 215,000 573,000
Proceeds from issuances of promissory notes payable, net 190,000 350,000
Net cash provided by financing activities 452,069 260,805 1,315,168 1,212,370
Net decrease in cash (182,652) (467,507) (530,708) (648,890)
Cash, Beginning of year 266,431 797,139 797,139 1,446,029
Cash, End of year 83,779 329,632 266,431 797,139
Supplemental disclosure of cash flow information:        
Cash paid for interest
Cash paid for income taxes
Schedule of non-cash Investing or Financing Activity:        
Common stock issued for accrued interest 21,743 131,681
Debt discount related to derivative liability 222,000 2,415,831
Reclass of derivative liability to equity 1,513,786    
Right-of-use assets obtained in exchange for operating lease obligations     103,107
Forgiveness of related party liabilities for sale of building to a related party     500,000
Common stock issued for convertible note payable     153,919
Convertible note in exchange for promissory note and accrued interest   $ 3,558,229